Day: July 17, 2023

Veritable to Combine with Pathstone

Written by Customer Service on July 17, 2023. Posted in Mergers And Acquisitions.

WEST PALM BEACH, Fla., July 17, 2023 (GLOBE NEWSWIRE) — Affiliated Managers Group, Inc. (NYSE: AMG), a leading partner to independent investment management firms globally, today announced that it has entered into an agreement with Pathstone Family Office, LLC (“Pathstone”) and Veritable, LP (”Veritable”), under which Pathstone will acquire 100% of the outstanding equity interests in Veritable. AMG will receive all of its transaction proceeds in cash at closing. “We are pleased to have had a strong partnership with Veritable, magnifying its growth and success over time,” said Jay C. Horgen, President and Chief Executive Officer of AMG. “The Veritable partners and AMG recognized the strategic benefits that would result from a combination with Pathstone, and given our alignment and partnership approach, we supported this successful...

Foresight Takes Major Step Toward Commercialization With Elbit Systems Securing Revenues up to $4 Million

Written by Customer Service on July 17, 2023. Posted in Public Companies.

The parties signed a five-year mutual exclusivity agreement commercializing Foresight’s proprietary software for semi- and fully-autonomous defense platforms Ness Ziona, Israel, July 17, 2023 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight”), an innovator in automotive vision systems, announced today the signing of an exclusive commercialization agreement with Elbit Systems Land Ltd. (“Elbit”), a subsidiary of Elbit Systems Ltd. (Nasdaq and TASE: ESLT), for the integration, marketing and licensing of Foresight’s image processing software solution. Foresight expects revenues of up to $4 million, over a contractual period of five years, with minimum guaranteed revenues of $1 million over that time period. The Company expects that it will start recognizing initial revenues from its agreement...

Jiuzi Holdings Inc. Announces Pricing of $2.3 Million Registered Direct Offering

Written by Customer Service on July 17, 2023. Posted in Public Companies.

HANGZHOU, China, July 17, 2023 (GLOBE NEWSWIRE) — Jiuzi Holdings, Inc. (NASDAQ: JZXN; the “Company”), a leading new energy vehicle (NEV) dealership group operating under the brand name “Jiuzi” in China, today announced that it entered into a securities purchase agreement with certain institutional investors to purchase $2.3 million worth of its ordinary shares in a registered direct offering. Under the terms of the securities purchase agreement, the Company has agreed to sell an aggregate of $2.3 million ordinary shares and/or pre-funded warrants in a registered direct offering. The purchase price per ordinary share is $1.65 and the purchase price for the pre-funded warrants is identical to the purchase price for ordinary shares, less the exercise price of $0.01 per share. The gross proceeds to the Company...

SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023

Written by Customer Service on July 17, 2023. Posted in Earnings Releases And Operating Results.

SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023 Results indicate 16-21% growth rate over Q2 2022, consistent with guidance provided in the Q1 2023 earnings release EDEN PRAIRIE, MN, July 17, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that revenues for the second quarter of 2023 (ending June 30) are expected to be in the range of $4.5 to $4.7 million, which is consistent with guidance provided in the Q1 2023 earnings release. “Despite ongoing production constraints discussed on the last earnings call, we are pleased to have been able to achieve our revenue growth guidance previously announced...

Bio-Path Holdings Announces Successful Completion of First Dose Cohort in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors

Written by Customer Service on July 17, 2023. Posted in Public Companies.

Advancing to Second Cohort of Phase 1/1b Clinical Trial Evaluating BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and Breast Cancer HOUSTON, July 17, 2023 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced completion of the first dose cohort of the dose escalation portion of its Phase 1/1b clinical trial of BP1001-A (liposomal Grb2) in patients with solid tumors, including ovarian, endometrial, pancreatic and breast cancer. “We are delighted to have completed the first cohort of this first-in-human Phase 1/1b study of BP1001-A as it further demonstrated the drug’s favorable safety profile, which is critical...

VICTORY UPDATES ANALYSIS FROM NEWLY NOTED INTRUSIVE ON ITS GEORGIA LAKE LITHIUM PROPERTY

Written by Customer Service on July 17, 2023. Posted in Public Companies.

Figure 1 Map of the Georgia Lake Property showing potential S-type granite trends, newly located feldspar porphyry, and a newly located intrusive body. The newly located intrusive body and feldspar porphyry are located in the southeastern section of the property. The green arrows indicate a potential S-type granite trend toward the property.VANCOUVER, BC, CANADA, July 17, 2023 (GLOBE NEWSWIRE) —The Georgia Lake Lithium Project is located in the Thunder Bay Lithium District, 2 km east of Rock Tech Lithium Inc.’s (TSXV: RCK) advanced lithium projectVictory’s just completed work program resulted in the discovery of a previously unmapped intrusive body and feldspar porphyry encountered at the southeast corner of the propertyThe significance of the newly noted features is that they show the potential of the property...

C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Written by Customer Service on July 17, 2023. Posted in Public Companies.

WATERTOWN, Mass., July 17, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 351,000 shares of the Company’s common stock to two new employees (the “Inducement Grants”), with grants made on July 10 and July 17, 2023 (the “Grant Dates”). The Inducement Grants were granted as inducements material to these individuals entering into employment with C4T in accordance with Nasdaq Listing Rule 5635(c)(4). The...

Methode Electronics Releases Inaugural Corporate Social Responsibility (CSR) Report

Written by Customer Service on July 17, 2023. Posted in Public Companies.

CHICAGO, July 17, 2023 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, LED lighting and power distribution applications, released its fiscal 2023 CSR report outlining Methode’s approach to environmental, social, and governance (ESG) initiatives. Methode’s ESG strategy builds upon its robust governance framework, commitment to a safe work environment, and focus on people. From progress made on waste management initiatives to ongoing commitments to diversity and inclusion, the report demonstrates how Methode has made an impact on its employees, communities and customers. President and Chief Executive Officer Donald W. Duda said, “I am proud of the work we have done to date and firmly believe that Methode is ready to deliver on our commitment to...

Biosenta Announces Termination of Joint Venture and Issuance of Securities

Written by Customer Service on July 17, 2023. Posted in Public Companies.

TORONTO, July 17, 2023 (GLOBE NEWSWIRE) — Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) is pleased to announce that it has completed its previously announced transaction to terminate its joint venture agreement between the Company and 19443391 Ontario Inc. (“194”) pursuant to a termination of joint venture agreement dated June 23, 2023 (the “Termination Agreement”) and issue to 194 3,000,000 common shares of the Company at a deemed issue price of $0.40 per share and a promissory note in the amount of $6,500,000 (the “Note”) as consideration (the “Transaction”). Value of Consideration The consideration received by 194 was determined based on the following:Pursuant to the joint venture agreement, Biosenta had agreed that 194 or its shareholders was to be paid at least $4,960,000 throughout the term of the joint venture...

US Smart PPE Technology Market Size to Surpass USD 3038.5 Million by 2030, exhibiting a CAGR of 16.8%

Written by Customer Service on July 17, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the US smart PPE technology market size is projected to reach USD 3038.5 million in 2030, at a CAGR of 16.8% during the forecast period, 2023-2030 Pune, India, July 17, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, US smart PPE technology market size was valued at USD 890.6 million in 2022 and is projected to grow from USD 1026.6 million in 2023 to USD 3038.5 million by 2030, exhibiting a CAGR of 16.8% during the forecast period. Adoption of PPE technology to enhance workplace safety and performance to drive the market. Fortune Business Insights presents this information in their report titled “US Smart PPE Technology Market Forecast, 2023-2030.”Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-smart-ppe-technology-market-107714Companies...

Day: July 17, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals